Form 4 for KYTX Kyverna Therapeutics, Inc.

Accepted 2026-01-14 00:00:00 ET · period of report 2026-01-12 · accession 0001193125-26-013021 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2026-01-14	2026-01-12	KYTX	Shaw Christi	Executive COB, Dir	A - Grant	$0.00	+54.3K	70.9K	+326%	$0
D	2026-01-14	2026-01-12	KYTX	Shaw Christi	Executive COB, Dir	A - Grant	$0.00	+185.0K	185.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-01-12	A	A	30,000	$0.00	46,634	D	—	—	(F1) Represents a restricted stock unit award of common stock, 1/4th of the shares subject to which shall vest on January 12, 2027, and 1/4th of the shares subject to the restricted stock unit award shall vest following each one-year period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
2	Common	Common Stock	2026-01-12	A	A	24,301	$0.00	70,935	D	—	—	(F2) Represents a performance restricted stock unit award of common stock, which will vest upon the Issuer's common stock achieving certain specified prices per share.
3	Derivative	Stock Option (right to buy)	2026-01-12	A	A	185,000	$0.00	185,000	D	$8.23 · — to 2036-01-11	185,000 Common Stock	(F3) 1/4th of the shares subject to the option shall vest on January 12, 2027, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.